CIS-induced oxidative stress (OS) also accelerates inflammatory cell damage by activating the nuclear factor kappa-B (NF-κB) pathway and by increasing the levels of pro-inflammatory cytokines, including interleukin-6 (IL-6) (3). Here, IL6 is linked to in situ carcinoma.